Article info

Download PDFPDF
Research paper
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Authors

  1. Correspondence to A/Prof Tomas Kalincik, CORe, Department of Medicine, University of Melbourne, Melbourne, VIC 3050, Australia; tomas.kalincik{at}unimelb.edu.au
View Full Text

Citation

Kalincik T, Kubala Havrdova E, Horakova D, et al
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Publication history

  • Received October 15, 2018
  • Revised December 7, 2018
  • Accepted December 14, 2018
  • First published January 13, 2019.
Online issue publication 
July 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.